CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Club degli Investitori

Andrea Rota, Managing Director

The Club Degli Investitori: Turin Startup Ecosystem

Andrea Rota

Andrea Rota

Italy has a dynamic, young, and growing innovation ecosystem, which counts approximately 14,000 startups. In 2022, Venture Capital investments reached €1.85Bn, marking a 48% growth compared to 2021 and bucking the European trend of an average decline of -16% .


But what are the main hubs of innovation in the country?


At the forefront is Milan, the capital of Italian innovation, which raised over €950M in 2022 and is home to both of the country's unicorns: fintech companies Scalapay and Satispay. Another main innovation hub is Turin, a city housing major companies and banks (such as Fiat, Intesa Sanpaolo), important universities (ESCP, Politecnico di Torino), and prominent centers of innovation (OGR-Officine Grandi Riparazioni, Talent Garden). Turin boasts 27 accelerators and 25 private or institutional investors, including the Club degli Investitori, the largest network of Italian business angels in the world. To better understand the characteristics and evolution of the city's innovation community, the Club degli Investitori conducts the "Turin Startup Ecosystem" research, now in its third edition. The aim is to gather elements that promote the birth and development of startups in Turin.


Research reveals that in 2022, investments in Turin[1]based startups doubled. Innovative companies raised €400M, which accounted for 22% of Venture Capital investments in Italy. 


Many of these investments were made in 'hi-tech' companies, including DeepTech, Energy & CleanTech, Life Sciences, Software & Cybersecurity, Mobility & Automotive, which represented 68% of the total innovative companies in Turin, again reinforcing Turin’s leadership in "hi-tech" investments. 


Furthermore, the analysis of investment rounds showed that 81% of startups that raised capital in 2022 have a I LAST WORD predominantly international focus. Among the top 10 companies in terms of round size, 100% are active in foreign markets or declare that they will use the raised capital to expand internationally.


"Turin is quickly becoming one of the most active entrepreneurial hotbeds in Italy"


We asked Andrea Rota, Managing Director of the Club degli Investitori, for a comment on the evolution of Turin: "Turin is quickly becoming one of the most active entrepreneurial hotbeds in Italy. Iconic location (OGR), Ambitious Scale-ups (Newcleo), Great Events (Italian Tech Week), top-notch technical universities (Politecnico di Torino) and great investors (Club degli Investitori, among others) are all part of the mix fueling this growth. Furthermore, Milan and Turin are connected by a 45’ high-speed rail train, and–when taken together–they form a super-ecosystem which can rival some of Europe’s largest innovation hubs”.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/the-club-degli-investitori-turin-startup-ecosystem-nwid-1599.html